Hospital Patient Care Pharmaceutical Radiation 
Imaging Technology
JANUARY 8, 2024
GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world. Together, we will build upon our shared legacies of enhancing patient care.”
Imaging Technology
APRIL 2, 2024
announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. There is also special focus on radiation therapy and Theranostics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
JULY 5, 2023
Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Ac-225 carries sufficient radiation to cause cell death in a localized area of targeted cells, while its half-life limits unwanted radioactivity in patients. NorthStar is positioned to be the first commercial-scale producer of n.c.a.
AuntMinnie
JUNE 3, 2024
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology. led by Harshad Kulkarni, MD, as principal investigator.
AuntMinnie
AUGUST 5, 2024
report of NSF in 33 dialysis patients at a St. Louis hospital. You know the next few suits will involve the hospital and the radiologists. In all cases, the hospital obtains verbal informed consent from patients receiving contrast. If you render appropriate patient care, that's the best protection."
Expert insights. Personalized for you.
105 
Let's personalize your content